Mr. Speaker, the industry committee is currently studying the patent medicine notice of compliance regulations in the pharmaceutical industry.
The Minister of Industry has an interesting history with the pharmaceutical industry, in particular when he broke the Patent Act to order Cipro, a generic drug not yet on the market.
Will the minister take the opportunity today to set the record straight for his government? Does he support the current notice of compliance regulations or not?